MacroGenics Inc. (MGNX) 在主动向美国食品药品监督管理局(FDA)通报其已暂停Linnet试验新参与者招募工作后,FDA已对该公司启动部分临床暂停。
MacroGenics Inc. (MGNX) 在主动向美国食品药品监督管理局(FDA)通报其已暂停Linnet试验新参与者招募工作后,FDA已对该公司启动部分临床暂停。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.